1. Home
  2. SPRO vs SUNS Comparison

SPRO vs SUNS Comparison

Compare SPRO & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.28

Market Cap

136.7M

Sector

Health Care

ML Signal

HOLD

Logo Sunrise Realty Trust Inc.

SUNS

Sunrise Realty Trust Inc.

HOLD

Current Price

$9.78

Market Cap

134.6M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPRO
SUNS
Founded
2013
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
136.7M
134.6M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
SPRO
SUNS
Price
$2.28
$9.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$5.00
$13.50
AVG Volume (30 Days)
281.7K
108.8K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
12.45%
EPS Growth
N/A
1112.46
EPS
N/A
1.09
Revenue
$40,549,000.00
$19,384,703.00
Revenue This Year
N/A
$174.58
Revenue Next Year
N/A
$60.45
P/E Ratio
N/A
$8.83
Revenue Growth
N/A
2540.16
52 Week Low
$0.51
$7.80
52 Week High
$3.22
$14.72

Technical Indicators

Market Signals
Indicator
SPRO
SUNS
Relative Strength Index (RSI) 45.17 46.17
Support Level $2.26 $9.31
Resistance Level $2.37 $10.13
Average True Range (ATR) 0.07 0.30
MACD -0.00 -0.06
Stochastic Oscillator 12.12 41.06

Price Performance

Historical Comparison
SPRO
SUNS

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About SUNS Sunrise Realty Trust Inc.

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.

Share on Social Networks: